Feng Su
Impact in
- Hepatology top 2%
- Liver Disease and Transplantation
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments
Papers in
- Hepatology 13
- Liver Disease and Transplantation 8
- Hepatitis C virus research 6
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Epidemiology 11
- Liver Disease Diagnosis and Treatment 11
- Hepatitis B Virus Studies 3
- Co-authors
- George N. Ioannou (8 shared papers)Kristin Berry (7 shared papers)Andrew M. Moon (6 shared papers)Charles Landis (1 shared paper)Lei Yu (1 shared paper)Jorgé Reyes (1 shared paper)Iris Liou (1 shared paper)Stephen C. Rayhill (1 shared paper)
- Journals
- Hepatology Communications (2 papers)Gastroenterology (2 papers)Clinical Cancer Research (1 paper)Journal of Hepatology (1 paper)Alimentary Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Feng Su
25 papers receiving 552 citations
Peers
Comparison fields: 5 of 65
- Hepatology 299
- Transplantation 34
- Epidemiology 267
- Reproductive Medicine 38
- Cancer Research 58
Countries citing papers authored by Feng Su
This map shows the geographic impact of Feng Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Su more than expected).
Fields of papers citing papers by Feng Su
This network shows the impact of papers produced by Feng Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Su. The network helps show where Feng Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 142 | |
| 2 | 2018 | 84 | |
| 3 | 2021 | 32 | |
| 4 | 2013 | 31 | |
| 5 | 2020 | 30 | |
| 6 | 2016 | 25 | |
| 7 | 2020 | 24 | |
| 8 | 2018 | 22 | |
| 9 | 2017 | 20 | |
| 10 | 2020 | 19 | |
| 11 | 2020 | 18 | |
| 12 | 2015 | 17 | |
| 13 | 2020 | 17 | |
| 14 | 2015 | 17 | |
| 15 | CXCR6 deficiency attenuates pressure overload-induced monocytes migration and cardiac fibrosis through downregulating TNF-α-dependent MMP9 pathway. | 2014 | 16 |
| 16 | 2020 | 10 | |
| 17 | 2011 | 9 | |
| 18 | 2017 | 8 | |
| 19 | 2023 | 4 | |
| 20 | 2018 | 2 |
About Feng Su
Feng Su is a scholar working on Hepatology, Epidemiology, Surgery, Molecular Biology and Pathology and Forensic Medicine, having authored 26 papers that have together received 554 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (11 papers), Liver Disease and Transplantation (8 papers), Hepatitis C virus research (6 papers), Organ Transplantation Techniques and Outcomes (4 papers), Hepatitis B Virus Studies (3 papers), Cardiac Fibrosis and Remodeling (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Alcohol Consumption and Health Effects (2 papers). The work is most often cited by research in Hepatology (299 citations), Transplantation (34 citations), Epidemiology (267 citations), Reproductive Medicine (38 citations) and Cancer Research (58 citations). Feng Su has collaborated with scholars based in United States, China and Canada. Frequent co-authors include George N. Ioannou, Kristin Berry, Andrew M. Moon, Charles Landis, Lei Yu, Jorgé Reyes, Iris Liou, Stephen C. Rayhill, Noel S. Weiss and Lauren A. Beste. Their work appears in journals such as Hepatology Communications, Gastroenterology, Clinical Cancer Research, Journal of Hepatology and Alimentary Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.